Laboratory tests to determine the cause of hypokalemia and paralysis

Archives of Internal Medicine

Volumn 164, Issue 14, 2004, Pages 1561-1566

  Lin, Shih Hua ^a   Lin, Yuh Feng ^a   Chen, Dung Tsa ^a   Chu, Pauling ^a   Hsu, Chin Wang ^b   Halperin, Mitchell L ^c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; POTASSIUM CHLORIDE;

ADULT; ARTERIAL PH; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; LABORATORY TEST; MALE; PARALYSIS; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RELIABILITY; URINALYSIS;

ADULT; CREATININE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOKALEMIA; MALE; PARALYSIS, HYPERKALEMIC PERIODIC; POTASSIUM; POTASSIUM CHLORIDE;

EID: 3242775337     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.14.1561     Document Type: Article

References (34)

1. Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation and therapy. Am J Emerg Med. 1992;10:143-146.
2. Ober KP. Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature. Medicine. 1992;71:109-120.
3. McFadzean AJS, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ. 1967;25:451-455.
4. Ko GT, Chow CC, Yeung VT, Chan HH, Li JK, Cockram CS. Thyrotoxic periodic paralysis in a Chinese population. QJM. 1996;89:463-468.
5. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis. 2001;37:620-623.
6. Huang YY, Hsu RS, Tsai JS. Paralytic myopathy: a leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab. 1996;81:4038-4041.
7. Dowd JE, Lipsky PE. Sjögren's syndrome presenting as hypokalemic periodic paralysis, Arthritis Rheum. 1993;36:1735-1738.
8. Ahlawat SK, Sachdev A. Hypokalemic paralysis. Postgrad Med J. 1999;75:193-197.
9. Lin SH, Lin YF, Halperin ML. Hypokalemia and paralysis. QJM. 2001;94:133-139.
10. West ML, Bendz O, Chen CB, et al. Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab. 1986;12:226-233.
11. Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990;15:309-315.
12. Cheng NL, Kao MC, Hsu YO, Lin SH. Novel thiazide-sensitive Na-Cl cotransporter mutation in a Chinese patient with Gitelman's syndrome presenting as hypokalaemic paralysis. Nephrol Dial Transplant. 2003;18:1005-1008.
13. Narins RG, Jones ER, Stom MC, Rudnick MR, Bastl CP. Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis. Am J Med. 1982;72:496-520.
14. Weiner ID, Wingo CS. Hypokalemia: consequences, causes and correction. J Am Soc Nephrol. 1997;8:1179-1188.
15. Gennari FJ. Hypokalemia. N Engl J Med. 1998;339:451-458.
16. Berl T, Linas SL, Aisenbrey GA, Anderson RJ. On the mechanism of polyuria in potassium depletion: the role of polyuria. J Clin Invest. 1977;60:620-625.
17. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S. Hypokalemia-induced down-regulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest. 1996;97:1960-1968.
18. West ML, Marsden PA, Richardson RMA, Zettle RM, Halperin ML. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab. 1986;12:234-238.
19. Halperin ML, Kamel KS. Electrolyte quintet: potassium. Lancet. 1998;352:35-40.
20. Kamel KS, Ethier JH, Richardson RM, Bear RA, Halperin ML. Urine electrolytes and osmolality: when and how to use them. Am J Nephrol. 1990;10:89-102.
21. Elisaf M, Siamopoulos KC. Fractional excretion of potassium in normal subjects and in patients with hypokalemia. Postgrad Med J. 1995;71:211-212.
22. Agarwal R, Afzalpurkar R, Fordtran JS. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology. 1994;107:548-571.
23. Kim HJ, Yoon YM, Park KN. The change in electrolytes and acid-base after artificially induced acute diarrhea by laxatives. J Korean Med Sci. 1994;9:388-393.
24. Conway MJ, Seibel JA, Eaton RP. Thyrotoxicosis and periodic paralysis: improvement with beta blockage. Ann Intern Med. 1974;81:332-336.
25. Kodali VRR, Jeffcote B, Clague RB. Thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med. 1999;17:43-45.
26. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999;159:601-606.
27. Sterns RH, Cox M, Feig PU, Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine. 1981;60:339-354.
28. Gallagher EJ. Is thyrotoxic periodic paralysis a channelopathy? J Emerg Med. 1999;17:123-127.
29. Dias da Silva MR, Cerutti JM, Tengan CH, et al. Mutations linked to familial hypokalemic periodic paralysis in the calcium channel α1 subunit gene (Cav1-1) are not associated with thyrotoxic hypokalemic periodic paralysis. Clin Endocrinol (Oxf). 2002;56:367-375.
30. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24-30.
31. Peters M, Jeck N, Reinalter SS, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112:183-190.
32. Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59:710-717.
33. Tang NL, Hui J, To KF, Ng HK, Hjelm NM, Fok TF. Severe hypokalemic myopathy in Gitelman's syndrome. Muscle Nerve. 1999;22:545-547.
34. Tajima T, Kobayashi Y, Abe S, et al. Two novel mutations of thiazide-sensitive Na-Cl cotransporter (TSC) gene in two sporadic Japanese patients with Gitelman syndrome. Endocr J. 2002;49:91-96.